3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Status
Unknown
2
Sponsor Class
OTHER_GOV
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Breast Neoplasms
11
Neoplasm Metastasis
7
Neoplasms
5
Carcinoma, Renal Cell
3
Tuberous Sclerosis
2
Triple Negative Breast Neoplasms
2
Recurrence
2
Prostatic Neoplasms
2
Neuroendocrine Tumors
2
Leukemia, Myeloid, Acute
2
Gastrointestinal Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Neuroendocrine
2
Thyroid Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Thyroid Cancer, Papillary
1
Sarcoma
1
Renal Cell Cancer Metastatic
1
Relapsed Pediatric Solid Tumor
1
Ovarian Neoplasms
1
Osteosarcoma
1
Nasopharyngeal Carcinoma
1
Metatropic dwarfism
1
Melanoma
1
Lymphoma
1
Liver Neoplasms
1
Liver Failure
1
Liver Diseases
1
Liver Cirrhosis
1
Leukemia, Myelomonocytic, Acute
1
Interventions
Gemcitabine
13
Oxaliplatin
9
Capecitabine
6
lenvatinib
5
apatinib
5
Cisplatin
5
tislelizumab
4
Surgical Procedures, Operative
4
Radiofrequency Ablation
4
Neoadjuvant Therapy
4
Fluorouracil
4
toripalimab
3
sintilimab
3
Radiotherapy
3
Leucovorin
3
Irinotecan
3
regorafenib
2
pembrolizumab
2
durvalumab
2
camrelizumab
2
Stents
2
Photochemotherapy
2
Immunotherapy
2
Hepatectomy
2
Folfox protocol
2
Everolimus
2
Drug Therapy
2
Cholangiopancreatography, Endoscopic Retrograde
2
Blood Specimen Collection
2
1-phenyl-3,3-dimethyltriazene
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Cholangiocarcinoma
×
Everolimus
×
Clear all
NCT01525719
2012-02-03
CRAD001T
Ratchavithi Hospital
Phase 2
Unknown
40 enrolled
NCT00973713
2009-09-09
RADiChol
Austin Health
Phase 2
Unknown
27 enrolled